6Pepe G,Rossetti C,Sironi S. Paticnts with know or suspected lung cancer:cvluation of clinical management changes due to 18aF-fluorodeoxyglucose positron emission tomography (18 F-FDG PET) study[J].Nuclear Medicine Communications,2005,(09):831-837.
7Bunyaviroch T,Goleman RE. PET evaluation of lung cancer[J].The Journal of Nuclear Medicine,2006,(03):451-469.
8Liang QL, Shi HZ, Qin XJ, et al. Diagnostic accuracy of turnout markers for malignant pleural effusion: a meta- analysis. THORAX,2008,63:35- 41.
9Osterheld MC, Liette L, Anca M. Image lytometry: an aid for cytologicai diagnosis of pleural effusions. Diagn Cytopathol, 2005, 32: 173- 176.
10Burgess L J, Maritz F J, Taljaard JJF. Comparative - analysis of the bio- chemical parameters used to distinguish between pleural transudates and exudates. Chest, 1995,107:1604- 1609.
5Zhang M,Jiang XF,Zhang M,et al.The role of 18F-FDG PET/CT in the evaluation of ascites of undetermined origin[J].J Nucl Med,2009,50(4):506-512.
6Rubini G,Altini C,Notaristefano A,et al.Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125[J].Rev Esp Med Nucl Imagen Mol,2014,33(1):22-27.
7Bamba Y,Itabashi M,Kameoka S.Clinical use of PET/CT in peritoneal carcinomatosis from colorectal cancer[J].Hepatogastroenterology,2012,59(117):1408-1411.
